• Antimicrobials used in this Programme:

    Not all Antimicrobials were tested in every country. Please see individual country study reports for more details.

  • Amoxicillin/clavulanate

    Other names: Co-arnoxiclav, Augmentinr Clavulin lass of agent: Penicillin and beta-lactamase inhibitor

  • Amoxicillin

    Other names: Amoxycillin Class of agent: Penicillin

  • Ampicillin

    Other names: Principen Class of agent: Penicillin

  • Azithromycin

    Zithromax, AvIhrocin Class of agent: Macrolide

  • Cofactor

    Other names: Biocef, Ceclor, Medacef, I eflor, Rariclor Class of agent: Second-generation cephalosporin

  • Ceftriaxone

    Other names: Rocephin, Epicephin Class of agent: Third-generation rephalosporin

  • Cefuroxime

    Other names: Zinacef, Cettin Class of agent: Second-generation cephaloeporin

  • Clarithromycin

    Other names: Biaxin Class of agent: Macrolide

  • Erythromycin

    Other names: Eryc, Erythrociin Class of agent: Macrolide

  • Levofloxacin

    Other names: Levaquin Class of agent: Fluoroquinolohe

  • Moxifloxacin

    Other names: Avelox, Vigamox, Moxez Class of agent: Fluoroquinolone

  • Penicillin

    Other names: Class of agent: Penicillin

  • Trimethoprim/sulfamethoxazole

    Other names: Bactrim,. Cotrim, Co-trimoxazole, Baktar Class of agent: Trimethoprim and sulfonamide

Years Active: 
2014-2016
Number of Countries: 
9
Countries: 
Romania, Bulgaria, Croatia, Serbia, Ukraine, Slovak Republic, Russia, Czech Republic, Greece
Primary objective: 
Data generation for antibiotic resistance of the main community-acquired respiratory tract infection pathogens such as Streptococcus pneumoniae and Haemophilus influenzae.
Types of Surveillance: 
Samples, primarily used for routine clinical practice, then used for surveillance.
Organism Identification: 
Local laboratories identify microorganisms based on their routinely used methodology. Then isolates are identified at third party's central laboratory to re-identify microorganisms and perform antibiotic susceptibility testing.
Methodology and Breakpoints: 
Broth microdilution according to Clinical And Laboratory Standards Institute (CLSI) guidelines.
Clinical Study Short Description: 
The SOAR study reports provides a detailed factual summary of the clinical information.
Data Sets Short Description: 
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed mauris ex